TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15985509

Group type: EXPERIMENTAL
Intervention: Acupuncture at the Quchi (LI11) acupoint thrice weekly for 1 month
Number of subjects: 40

Group type: COMPARATOR
Intervention: Acupuncture at a non‐acupoint 2 cm lateral to Quchi (LI11) thrice weekly for 1 month
Number of subjects: 40
Study: 15270401

Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 10

Group type: COMPARATOR
Intervention: US
Number of subjects: 10
Study: 11331120

Group type: EXPERIMENTAL
Intervention: Self-reported weight
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Self-reported height
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Self-reported BMI
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Employment status
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Self-reported eligibility
Number of subjects: 97
Study: 9154882

Group type: EXPERIMENTAL
Intervention: Isoniazid (oral administration)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: NAT2 allele composition
Number of subjects: 60
Study: 7955261

Group type: EXPERIMENTAL
Intervention: Normothermic CPB (warm, > 34 degrees C)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Hypothermic CPB (cold, ≤ 28 degrees C)
Number of subjects: 201
Study: 3297445

Group type: EXPERIMENTAL
Intervention: Magnesium infusion
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 130
Study: 30823886

Group type: EXPERIMENTAL
Intervention: Conditional cash transfer for ANC health visits, facility birth, and postnatal care (PNC) visits until the newborn reaches 1 year of age.
Number of subjects: 7200
Study: 28489142

Group type: EXPERIMENTAL
Intervention: Cognitive cooperation group (20 sessions of 1.5 hours each)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Routine medical care (control group)
Number of subjects: 293
Study: 25435134

Group type: EXPERIMENTAL
Intervention: RRCB
Number of subjects: 50
Study: 24120430

Group type: EXPERIMENTAL
Intervention: Mindfulness Based Stress Reduction (MBSR)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 14
Study: 21690572

Group type: EXPERIMENTAL
Intervention: Vinorelbine or paclitaxel-containing chemotherapy
Number of subjects: 443
Study: 18646333

Group type: EXPERIMENTAL
Intervention: STEP (School‐based Teenage Education Program focusing on HIV Prevention)
Number of subjects: 1846
Study: 16682679

Group type: EXPERIMENTAL
Intervention: Rasagiline
Number of subjects: 0
Study: 12756055

Group type: EXPERIMENTAL
Intervention: Modified Antenatal Care (ANC) protocol
Number of subjects: 164

Group type: COMPARATOR
Intervention: Traditional ANC protocol
Number of subjects: 164
Study: 11090595

Group type: EXPERIMENTAL
Intervention: 6.0 g fish oil daily for 6 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: No supplementation
Number of subjects: 20
Study: 9099186

Group type: EXPERIMENTAL
Intervention: Task-related training program involving practice of reaching beyond arm's length.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham training involving cognitive-manipulative tasks within arm's length.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Task-related training program.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (sham training).
Number of subjects: 20
Study: 1372028

Group type: EXPERIMENTAL
Intervention: Acute treatment with retinoic acid (4 days)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Chronic treatment with retinoic acid (16 weeks)
Number of subjects: 29
Study: 3888046

Group type: EXPERIMENTAL
Intervention: Synthetic androgen fluoxymesterone for 3 days before and on the day of chemotherapy
Number of subjects: 41

Group type: COMPARATOR
Intervention: Aminoglutethimide and hydrocortisone plus cyclic chemotherapy
Number of subjects: 41
Study: 31562291

Group type: EXPERIMENTAL
Intervention: Households with reported domestic accidents (10.2%)
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: Households with overcrowding
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: Households with safety practices
Number of subjects: 578
Study: 31813295

Group type: EXPERIMENTAL
Intervention: CT/MR‐CEUS Fusion Imaging
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: 3DUS‐CEUS Fusion Imaging
Number of subjects: 374

Group type: EXPERIMENTAL
Intervention: CEUS
Number of subjects: 374
Study: 27816730

Group type: EXPERIMENTAL
Intervention: Computer-Assisted Navigation System (CANS)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control (no CANS)
Number of subjects: 103
Study: 26078250

Group type: EXPERIMENTAL
Intervention: Genotype AG (minor allele)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: FADS2 index (DHA:EPA ratio)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Genotype GG and AG (both breastfed)
Number of subjects: 240
Study: 23278841

Group type: EXPERIMENTAL
Intervention: BFRT LV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BFRT HV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HIT
Number of subjects: 0

Group type: COMPARATOR
Intervention: CON
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All training groups (BFRT LV, BFRT HV, HIT)
Number of subjects: 0
Study: 21859314

Group type: EXPERIMENTAL
Intervention: Ozone application followed by acid etching
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Acid etching followed by ozone application
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ozone and application of sodium ascorbate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Not treated with ozone (Control Group 1)
Number of subjects: 40
Study: 19107582

Group type: COMPARATOR
Intervention: Placebo response
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neurobiology of rehearsing or visualizing wellness
Number of subjects: 0
Study: 17429350

Group type: EXPERIMENTAL
Intervention: Vaporization using the Volcano device
Number of subjects: 18

Group type: COMPARATOR
Intervention: Smoking marijuana in a standard cigarette
Number of subjects: 18
Study: 14732657

Group type: EXPERIMENTAL
Intervention: delta‐aminolevulinic acid (delta‐ALA) followed by exposure to 10 J/cm(2) of blue light
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 40% urea cream applied to half of the treatment area
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: topical 3% lidocaine hydrochloride applied 45 minutes before treatment
Number of subjects: 18

Group type: COMPARATOR
Intervention: vehicle cream applied to half of the treatment area
Number of subjects: 18

Group type: COMPARATOR
Intervention: vehicle cream applied 45 minutes before treatment
Number of subjects: 18
Study: 12003483

Group type: EXPERIMENTAL
Intervention: CrossAction manual toothbrush
Number of subjects: 113

Group type: COMPARATOR
Intervention: Actibrush battery-operated power toothbrush
Number of subjects: 113
Study: 9563529

Group type: EXPERIMENTAL
Intervention: Early laparoscopic cholecystectomy within 72 hours of admission
Number of subjects: 99

Group type: COMPARATOR
Intervention: Delayed laparoscopic cholecystectomy after initial medical treatment
Number of subjects: 99
Study: 7931478

Group type: EXPERIMENTAL
Intervention: 3 x CMF + TAM
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: 6 x CMF
Number of subjects: 473

Group type: COMPARATOR
Intervention: 3 x CMF
Number of subjects: 473

Group type: EXPERIMENTAL
Intervention: TAM
Number of subjects: 473
Study: 3068038

Group type: EXPERIMENTAL
Intervention: Amphotericin B infusion at a rapid rate (45 minutes)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Amphotericin B infusion at a slow rate (2 hours)
Number of subjects: 17
Study: 31036107

Group type: EXPERIMENTAL
Intervention: Flap fixation technique
Number of subjects: 70

Group type: COMPARATOR
Intervention: Non-flap fixation (control group)
Number of subjects: 70
Study: 29023613

Group type: EXPERIMENTAL
Intervention: rhPDGF-BB-coated equine-derived bone matrix
Number of subjects: 32

Group type: COMPARATOR
Intervention: rhPDGF-BB-coated β-TCP
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study: 25802354

Group type: EXPERIMENTAL
Intervention: Pimecrolimus 1% cream (PIM)
Number of subjects: 2418

Group type: COMPARATOR
Intervention: Topical corticosteroids (TCSs)
Number of subjects: 2418
Study: 23415344

Group type: EXPERIMENTAL
Intervention: Short-term educational intervention (24 units) in human biology based on Evidence-based Medicine (EbM) and Good Scientific Practice (GSP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Short-term intervention in human biology without EbM and GSP
Number of subjects: 0
Study: 21857315

Group type: EXPERIMENTAL
Intervention: 1-hour supervised gym class three times a week plus monthly nutritional counseling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monthly workshops to discuss the importance of physical activity and receive nutritional counseling
Number of subjects: 0
Study: 19799472

Group type: EXPERIMENTAL
Intervention: Sinfrontal
Number of subjects: 113
Study: 16107866

Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg oral daily
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 14871283

Group type: EXPERIMENTAL
Intervention: Balsalazide (750 mg capsules, two capsules twice daily, increased by 750 mg increments to a maximum of 6 g for up to 7 days)
Number of subjects: 128
Study: 14673962

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral/pharmacologic group (CB-PHARM)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Attention-control/pharmacologic group
Number of subjects: 54

Group type: COMPARATOR
Intervention: Pharmacologic control group
Number of subjects: 54

Group type: COMPARATOR
Intervention: Aggregated pharmacologic group
Number of subjects: 54

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 54
Study: 10096243

Group type: EXPERIMENTAL
Intervention: FAC/FEC (5-fluorouracil, doxorubicin or epirubicin and cyclophosphamide)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Doxorubicin or epirubicin alone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: FAC/FEC treatment
Number of subjects: 60
Study: 7730008

Group type: EXPERIMENTAL
Intervention: Nursing model implementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control ward
Number of subjects: 0
Study: 2353184

Group type: EXPERIMENTAL
Intervention: Membrane oxygenator
Number of subjects: 96

Group type: COMPARATOR
Intervention: Bubble oxygenator
Number of subjects: 96
Study: 582796

Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Alcohol + Caffeine
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 30829429

Group type: EXPERIMENTAL
Intervention: Fentanyl 1 µg kg‐1 h‐1
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dexmedetomidine 0.5 µg kg‐1 h‐1
Number of subjects: 24
Study: 25794307

Group type: EXPERIMENTAL
Intervention: Deep dry needling (DDN) on 1 active and 1 latent myofascial trigger point (MTrP) of the infraspinatus muscle
Number of subjects: 20

Group type: COMPARATOR
Intervention: Deep dry needling (DDN) on only 1 active MTrP
Number of subjects: 20
Study: 27139255

Group type: EXPERIMENTAL
Intervention: Day-time orthosis (DO)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Night-time orthosis (NiO)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No orthosis (NoO)
Number of subjects: 20
Study: 24210889

Group type: EXPERIMENTAL
Intervention: AHA 2010 guidelines
Number of subjects: 86

Group type: COMPARATOR
Intervention: AHA 2005 guidelines
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: AHA 2010 guidelines (females)
Number of subjects: 86
Study: 22129516

Group type: EXPERIMENTAL
Intervention: dSBP/dHR index (autonomic nervous system regulation index)
Number of subjects: 577
Study: 19409342

Group type: EXPERIMENTAL
Intervention: Self‐ligating bracket system (SmartClip, 3M Unitek)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conventional preadjusted edgewise twin bracket (Victory, 3M Unitek)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both bracket systems
Number of subjects: 66
Study: 17672173

Group type: EXPERIMENTAL
Intervention: RRMT-3 (3 days per week)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: RRMT-5 (5 days per week)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: RRMT-M (2 days per week)
Number of subjects: 20
Study: 15601894

Group type: EXPERIMENTAL
Intervention: 3.0-T diffusion-weighted MR imaging
Number of subjects: 25

Group type: COMPARATOR
Intervention: 1.5-T diffusion-weighted MR imaging
Number of subjects: 25
Study: 12521277

Group type: EXPERIMENTAL
Intervention: Vitamin D (300,000 units, intramuscularly)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Calcium lactate (3 g daily)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Combination of vitamin D and calcium
Number of subjects: 42

Group type: COMPARATOR
Intervention: Calcium alone
Number of subjects: 42
Study: 9806564

Group type: EXPERIMENTAL
Intervention: Fixed-dose regimen
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Low-dose step-up regimen
Number of subjects: 37

Group type: COMPARATOR
Intervention: Step-down regimen
Number of subjects: 37
Study: 8929938

Group type: EXPERIMENTAL
Intervention: Integrated comprehensive residential services
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: On-site shelter-based intensive case management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care shelter services with case management
Number of subjects: 0
Study: 29579499

Group type: EXPERIMENTAL
Intervention: Narrative intervention
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study: 27020850

Group type: EXPERIMENTAL
Intervention: Music intervention during recovery period
Number of subjects: 143

Group type: COMPARATOR
Intervention: Neutral control stimulus during recovery period
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Acute stress (CO2 stress test)
Number of subjects: 143
Study: 25127878

Group type: EXPERIMENTAL
Intervention: Qigong intervention (2-hour group training twice a week for 6 weeks, 1-hour follow-up group session once a week for 4 months, 30-minute self-practice daily for 5.5 months)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Wait-list control group (received qigong training after the intervention group)
Number of subjects: 240
Study: 24321402

Group type: EXPERIMENTAL
Intervention: Pre-conception treatment including dental scaling and root planning, supragingival prophylaxis, and oral hygiene education
Number of subjects: 470

Group type: COMPARATOR
Intervention: Control group receiving supragingival prophylaxis and oral hygiene education
Number of subjects: 470
Study: 20599049

Group type: EXPERIMENTAL
Intervention: Neodymium magnets delivering 15 mTesla (mT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Neodymium magnets delivering 45 mTesla (mT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonmagnetic disk (sham control)
Number of subjects: 60
Study: 18464278

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (5 mg/kg/day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 16943400

Group type: EXPERIMENTAL
Intervention: 200 mg celecoxib twice daily
Number of subjects: 2005

Group type: EXPERIMENTAL
Intervention: 400 mg celecoxib twice daily
Number of subjects: 2005

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2005
Study: 12867305

Group type: EXPERIMENTAL
Intervention: Biphasic truncated exponential (BTE) shocks of 200 J
Number of subjects: 120

Group type: COMPARATOR
Intervention: Monophasic damped sine (MDS) shocks of 200 J
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Biphasic truncated exponential (BTE) shocks
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Termination of VF at 5 s
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Survival to hospital discharge
Number of subjects: 120
Study: 11111146

Group type: EXPERIMENTAL
Intervention: Repeated thrombolysis with rt‐PA
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 8959426

Group type: EXPERIMENTAL
Intervention: Seven-session structured-group habit reversal treatment
Number of subjects: 16

Group type: COMPARATOR
Intervention: Comparison group (no treatment)
Number of subjects: 16
Study: 1389195

Group type: EXPERIMENTAL
Intervention: Blind oral intubation without the use of a laryngoscope (Group 2)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Direct laryngoscopy using a Macintosh #3 blade (Group 1)
Number of subjects: 100
Study: 3886274

Group type: EXPERIMENTAL
Intervention: Group I (treatment)
Number of subjects: 629

Group type: EXPERIMENTAL
Intervention: Group II (treatment)
Number of subjects: 629
Study: 29331538

Group type: EXPERIMENTAL
Intervention: Moderately high-protein (MHP) diet
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Low-fat (LF) diet
Number of subjects: 107
Study: 28566534

Group type: EXPERIMENTAL
Intervention: PPEP-Pituitary
Number of subjects: 174
Study: 26259838

Group type: EXPERIMENTAL
Intervention: DAS28 REM
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: SDAI REM
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: SDAI LDA
Number of subjects: 610
Study: 23461433

Group type: EXPERIMENTAL
Intervention: U-CARE programme
Number of subjects: 53
Study: 21936907

Group type: EXPERIMENTAL
Intervention: Restrictive red cell transfusion strategy (target hemoglobin of 70‐90 g/L)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Liberal red cell transfusion strategy (target hemoglobin of 90‐110 g/L)
Number of subjects: 100
Study: 18201643

Group type: EXPERIMENTAL
Intervention: Provider cueing (using summary 'cueing sheets')
Number of subjects: 286

Group type: COMPARATOR
Intervention: Control group (no cueing)
Number of subjects: 286
Study: 16357546

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided injection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Blind injection
Number of subjects: 40
Study: 12499051

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) concentration of 8-hydroxyguanosine (8-OHG) in PD patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) concentration of 8-hydroxyguanosine (8-OHG) with duration of disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serum concentration of 8-hydroxyguanosine (8-OHG) in PD patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correlation of 8-hydroxyguanosine (8-OHG) concentrations in CSF and serum
Number of subjects: 0
Study: 10817793

Group type: EXPERIMENTAL
Intervention: Cisplatin-based chemotherapy (3 courses)
Number of subjects: 688

Group type: COMPARATOR
Intervention: Not receiving cisplatin-based chemotherapy (control group)
Number of subjects: 688

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 688
Study: 8653493

Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulfate (SLS) toothpaste
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Cocoamidopropyl‐betaine (CAPB) toothpaste
Number of subjects: 28

Group type: COMPARATOR
Intervention: Detergent-free toothpaste
Number of subjects: 28
Study: 1511812

Group type: EXPERIMENTAL
Intervention: Oxygenating mouthguard (3 liters/min)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Standard mouthguard
Number of subjects: 263
Study: 6149824

Group type: EXPERIMENTAL
Intervention: Postexercise systolic blood pressure recovery ratios at 1, 2, and 3 minutes after exercise in normal subjects
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Postexercise systolic blood pressure recovery ratios at 1, 2, and 3 minutes after exercise in patients with CAD
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Abnormal recovery ratios in patients with CAD
Number of subjects: 87

Group type: COMPARATOR
Intervention: Treadmill exercise test on placebo and beta-blocker in patients with CAD
Number of subjects: 87
Study: 29530353

Group type: EXPERIMENTAL
Intervention: Endocuff
Number of subjects: 1188

Group type: EXPERIMENTAL
Intervention: EndoRings
Number of subjects: 1188

Group type: EXPERIMENTAL
Intervention: Standard HD colonoscopy
Number of subjects: 1188

Group type: COMPARATOR
Intervention: FUSE
Number of subjects: 1188
Study: 27547026

Group type: EXPERIMENTAL
Intervention: Harmonic scalpel
Number of subjects: 198

Group type: COMPARATOR
Intervention: Conventional monopolar electrocautery
Number of subjects: 198
Study: 24317453

Group type: EXPERIMENTAL
Intervention: Venlafaxine 75 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 23621628

Group type: EXPERIMENTAL
Intervention: Trabeculectomy with intracameral and subconjunctival injections of bevacizumab (1.25 mg/0.05 mL) and subconjunctival injections of 5‐FU (5.0 mg/0.5 mL)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Trabeculectomy with 5‐FU (5.0 mg/0.5 mL)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study: 20721903

Group type: EXPERIMENTAL
Intervention: Pentagastrin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cognitive intervention (facilitate coping or increase sense of control)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 18845667

Group type: EXPERIMENTAL
Intervention: Intracoronary bone marrow cells (BMCs)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo medium
Number of subjects: 80
Study: 17029631

Group type: EXPERIMENTAL
Intervention: Amlodipine and AII antagonist
Number of subjects: 0

Group type: COMPARATOR
Intervention: AII antagonist
Number of subjects: 0
Study: 15451146

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 1778

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 1778
Study: 11176090

Group type: EXPERIMENTAL
Intervention: Lightwand intubation without cricoid pressure
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lightwand intubation with cricoid pressure
Number of subjects: 60
Study: 9038037

Group type: EXPERIMENTAL
Intervention: Felodipine ER 2.5 mg (F2.5)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Felodipine ER 5 mg (F5)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Nifedipine Retard 10 mg (N20)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Nifedipine Retard 20 mg (N40)
Number of subjects: 115
Study: 8430728

Group type: EXPERIMENTAL
Intervention: Healon
Number of subjects: 59

Group type: COMPARATOR
Intervention: Viscoat
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Healon (iris-plane phacoemulsification)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Viscoat (iris-plane phacoemulsification)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Healon (posterior-chamber phacoemulsification)
Number of subjects: 59
Study: 2885573

Group type: EXPERIMENTAL
Intervention: lymphoblastoid interferon for six months
Number of subjects: 46

Group type: COMPARATOR
Intervention: no therapy (control)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: lymphoblastoid interferon
Number of subjects: 46